Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Other Non-Current Liabilities: 2011-2025

Historic Other Non-Current Liabilities for Adma Biologics (ADMA) over the last 10 years, with Sep 2025 value amounting to $90,000.

  • Adma Biologics' Other Non-Current Liabilities fell 76.00% to $90,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $90,000, marking a year-over-year decrease of 76.00%. This contributed to the annual value of $360,000 for FY2024, which is 14.08% down from last year.
  • As of Q3 2025, Adma Biologics' Other Non-Current Liabilities stood at $90,000, which was up 4,400.00% from $2,000 recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Other Non-Current Liabilities ranged from a high of $789,534 in Q2 2021 and a low of $2,000 during Q1 2025.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $375,000 (2024), whereas its average is $296,899.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first spiked by 821.02% in 2021, then tumbled by 99.51% in 2025.
  • Adma Biologics' Other Non-Current Liabilities (Quarterly) stood at $397,351 in 2021, then decreased by 11.92% to $350,000 in 2022, then rose by 19.71% to $419,000 in 2023, then decreased by 14.08% to $360,000 in 2024, then plummeted by 76.00% to $90,000 in 2025.
  • Its Other Non-Current Liabilities stands at $90,000 for Q3 2025, versus $2,000 for Q2 2025 and $2,000 for Q1 2025.